| Michele Galvin, RPH | |
|
7975 E Us Highway 36, Avon, IN 46123-7975 | |
| (317) 272-5563 | |
| Not Available |
| Full Name | Michele Galvin |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 7975 E Us Highway 36, Avon, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295015915 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 26018254 (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michele Galvin, RPH 7975 E Us Highway 36, Avon, IN 46123-7975 Ph: (317) 272-5563 | Michele Galvin, RPH 7975 E Us Highway 36, Avon, IN 46123-7975 Ph: (317) 272-5563 |
News Archive
Ardelyx, Inc., a clinical-stage company focused on enhancing the treatment of patients with gastrointestinal and cardiorenal diseases, today announced the initiation of a Phase 3 clinical trial and an onset-of-action clinical trial evaluating RDX7675 in patients with hyperkalemia, a potentially life-threatening condition common in patients with cardiorenal disease.
An analysis of comparative effectiveness studies finds that few compare medications with nonpharmacologic interventions, and few examine safety or cost-effectiveness, according to a study in the March 10 issue of JAMA.
The Wall Street Journal reports that drug companies are increasingly using medical science liaisons: "Pharmaceutical companies are barred by the Food and Drug Administration from promoting unapproved drug uses, called off-label use, but they are using employees called 'medical science liaisons,' who are often physicians and pharmacists, as a legal way to discuss those uses.
National lupus organizations in more than 28 countries, and individuals with lupus and their families around the world, are rallying to protect access to new treatments and the development of future therapies to treat lupus.
A new study provides fresh evidence that the decline in the capacity of brain cells to change, called "plasticity," rather than a decline in total cell number may underlie some of the sensory and cognitive declines associated with normal brain aging.
› Verified 2 days ago
Ms. Leslie Deann Wells, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1074 N Avon Ave, Avon, IN 46123 Phone: 317-272-2133 Fax: 317-272-5061 | |
Ms. Angela Marie Swiezy, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7990 E Us Highway 36, Avon, IN 46123 Phone: 317-272-0242 | |
Julie Kippenbrock, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7975 E Us Highway 36, Avon, IN 46123 Phone: 317-272-5563 | |
Dr. Beverly Rachel Bortz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1074 N Avon Ave, Avon, IN 46123 Phone: 317-272-2133 | |
David Errett, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9500 E Us Highway 36, Avon, IN 46123 Phone: 317-209-8204 | |
Jillian Ashley Mcelmurry-dobin, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7975 E Us Highway 36, Avon, IN 46123 Phone: 317-272-5563 Fax: 317-272-7061 | |
Mrs. Kara Anne Appell, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10209 E Us Highway 36, Avon, IN 46123 Phone: 317-271-6598 |